KSHV

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instance_of gptkb:virus
gptkbp:belongs_to Herpesviridae family
gptkbp:can_cause immunosuppression
gptkbp:can_detect breast milk
saliva
semen
gptkbp:cause gptkb:Kaposi's_sarcoma
lymphoproliferative disorders
B-cell malignancies
vascular tumors
gptkbp:communication_system organ transplantation
sexual contact
blood transfusion
gptkbp:diagnosis biopsy
serological tests
PCR testing
gptkbp:discovered_by gptkb:1994
gptkbp:endemic_to gptkb:sub-Saharan_Africa
Mediterranean region
parts of South America
gptkbp:has_vaccine no vaccine available
https://www.w3.org/2000/01/rdf-schema#label KSHV
gptkbp:is_associated_with gptkb:multicentric_Castleman_disease
gptkb:primary_effusion_lymphoma
immunocompromised individuals
transplant recipients
HIV-positive patients
gptkbp:is_characterized_by latency
lytic replication
gptkbp:is_considered_as emerging infectious disease
opportunistic infection
gptkbp:is_monitored_by blood tests
imaging studies
clinical evaluations
gptkbp:is_part_of infectious disease studies
herpesvirus family
viral oncogenesis research
gptkbp:is_related_to gptkb:HIV
gptkb:AIDS
gptkbp:is_studied_for therapeutic interventions
cancer research
vaccine development
viral pathogenesis
gptkbp:is_studied_in clinical trials
gptkbp:known_as gptkb:Human_herpesvirus_8
gptkbp:seed_dispersal double-stranded DNA
gptkbp:symptoms weight loss
fever
swelling
night sweats
lesions
gptkbp:treatment radiation therapy
chemotherapy
antiviral therapy
gptkbp:bfsParent gptkb:human_herpesvirus_8
gptkb:Kaposi's_sarcoma-associated_herpesvirus
gptkbp:bfsLayer 5